Clinical

Dataset Information

0

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis


ABSTRACT: RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of celecoxib may keep polyps and colorectal cancer from forming in patients with familial adenomatous polyposis. PURPOSE: This randomized phase I trial is studying the side effects and best dose of celecoxib in treating young patients with a genetic predisposition for familial adenomatous polyposis.

DISEASE(S): Colon Cancer,Adenomatous Polyposis Coli,Colorectal Cancer,Colorectal Neoplasms,Precancerous Condition,Precancerous Conditions

PROVIDER: 2055970 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2007350 | ecrin-mdr-crc
| 2004196 | ecrin-mdr-crc
2021-09-22 | GSE180160 | GEO
2017-06-19 | GSE88945 | GEO
2018-04-16 | GSE106500 | GEO
2019-01-15 | GSE109507 | GEO
2023-08-07 | GSE189035 | GEO
| PRJNA431265 | ENA
2022-10-13 | GSE207398 | GEO
| PRJNA432077 | ENA